SLC7A5 and non-small cell lung carcinoma: In a pathological correlation study of non-small cell lung cancer (NSCLC) clinical stages I−III, the 5-year survival rate of SLC7A5-positive patients was significantly lower than that of SLC7A5-negative patients (78).